Reuters Health: Merkel cell cancers recur more often than other skin cancers
UC expert says early detection of recurrence is important for treatment
New research shows that Merkel cell carcinoma (MCC) recurs in patients much more often than other skin cancers, often within three years of diagnosis.
MCC is a more rare skin cancer that usually appears as a flesh-colored or bluish-red nodule on the skin, often on the face, head or neck.
Rekha Chaudhary, MD, adjunct associate professor at the UC College of Medicine and a UC Health oncologist, reviewed the research and told Reuters Health that new immunotherapy treatments have proven effective against MCC recurrence, making early detection of recurrence important.
"This study was very helpful in predicting those rates of recurrence," she said. "Following an MCC patient who has had a complete resection closely is very important now, given the new innovative treatments, and national guidelines should be adjusted accordingly."
Read the Reuters Health article.
Featured photo at top of Dr. Chaudhary. Photo/Colleen Kelley/University of Cincinnati.
Related Stories
Alabama.com: How a new self-test for HPV could be a game changer
April 19, 2024
The University of Cincinnati's Leeya Pinder was featured in an Alabama.com/Reckon article about how self-testing for HPV could make preventative care more accessible to those facing the most barriers.
Dr. Karen Craven honored with Service-Learning award
April 19, 2024
Dr. Karen Craven, assistant professor of occupational therapy in the College of Allied Health Sciences, receives 2024 Jack Twyman Award for Service-Learning.
Julie Leftwich appointed Director of International Peace and...
April 18, 2024
Julie Leftwich appointed Director of International Peace and Security Initiatives at the University of Cincinnati College of Law.